TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33758306

Group type: EXPERIMENTAL
Intervention: High-cornstarch diet (36%)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Medium-cornstarch diet (18%)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Low-cornstarch diet (0%)
Number of subjects: 360
Study: 32131365

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (1000 IU/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33155824

Group type: EXPERIMENTAL
Intervention: Closed-loop control (CLC) system
Number of subjects: 168

Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 168
Study: 32707571

Group type: EXPERIMENTAL
Intervention: Cd85‐xMgxTb15 alloys with varying x (5, 10, 15, 20)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transmission electron microscopy analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemical disorder due to randomized substitution of Cd with Mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orientational disorder of the Cd4 tetrahedra
Number of subjects: 0
Study: 35038015

Group type: EXPERIMENTAL
Intervention: Model-assisted training (group A)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Traditional training (group B)
Number of subjects: 92
Study: 33891615

Group type: EXPERIMENTAL
Intervention: ARB/ACEI
Number of subjects: 210

Group type: COMPARATOR
Intervention: non-ARB/ACEI
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: ARB
Number of subjects: 210

Group type: COMPARATOR
Intervention: ACEI
Number of subjects: 210
Study: 35615041

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) for remote patient monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mHealth tools (apps and wearables)
Number of subjects: 0
Study: 36372347

Group type: EXPERIMENTAL
Intervention: MNV type 3
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: MNV type 1
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: MNV type 2
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Mixed type 1 and 2
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Fellow eye MA
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment
Number of subjects: 1097
Study: 33054811

Group type: EXPERIMENTAL
Intervention: Home-based ReHub-assisted telerehabilitation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard rehabilitation during the 2-week stay in the rehabilitation clinic followed by 3 weeks of unsupervised home-based rehabilitation
Number of subjects: 56
Study: 35179431

Group type: EXPERIMENTAL
Intervention: Qigong exercise program
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study: 33154085

Group type: EXPERIMENTAL
Intervention: Angiotensin II-stimulating antihypertensives
Number of subjects: 1909

Group type: COMPARATOR
Intervention: Angiotensin II-inhibiting antihypertensives
Number of subjects: 1909

Group type: EXPERIMENTAL
Intervention: Both antihypertensive types
Number of subjects: 1909
Study: 32807086

Group type: EXPERIMENTAL
Intervention: Statin therapy (rosuvastatin)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Non-statin therapy (placebo)
Number of subjects: 227
Study: 35410935

Group type: EXPERIMENTAL
Intervention: Two video consultations conducted by a mental health specialist (MHS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Five video consultations conducted by a mental health specialist (MHS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Enhanced treatment as usual provided by their GP
Number of subjects: 50
Study: 33931037

Group type: EXPERIMENTAL
Intervention: Papacarie-Duo
Number of subjects: 162

Group type: COMPARATOR
Intervention: ART
Number of subjects: 162
Study: 35070197

Group type: EXPERIMENTAL
Intervention: NASM exercise program
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: PRI exercise program
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: NASM-PRI integration exercise program
Number of subjects: 33
Study: 32108364

Group type: EXPERIMENTAL
Intervention: Deterministic statements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control statements
Number of subjects: 0
Study: 36281908

Group type: EXPERIMENTAL
Intervention: US-guided cannulation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional cannulation
Number of subjects: 50
Study: 34103643

Group type: EXPERIMENTAL
Intervention: BMI < 25 kg/m2
Number of subjects: 1319

Group type: EXPERIMENTAL
Intervention: ≥ 5 servings of fruits or vegetables/day
Number of subjects: 1319

Group type: EXPERIMENTAL
Intervention: ≤ 2 alcoholic drinks/day for men or 1 drink/day for women
Number of subjects: 1319

Group type: EXPERIMENTAL
Intervention: ≥ 30 min of moderate or vigorous physical activity/day
Number of subjects: 1319
Study: 33222306

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36081312

Group type: EXPERIMENTAL
Intervention: Tongue elevation training for 6 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham training protocol (control) for 6 weeks
Number of subjects: 27
Study: 33358350

Group type: EXPERIMENTAL
Intervention: GTN sublingual powder
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 32817724

Group type: EXPERIMENTAL
Intervention: Non-commercial funders with a data-sharing policy
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Commercial funders with a data-sharing policy
Number of subjects: 178

Group type: COMPARATOR
Intervention: RCTs funded by non-commercial funders
Number of subjects: 178

Group type: COMPARATOR
Intervention: RCTs funded by commercial funders
Number of subjects: 178
Study: 35847464

Group type: EXPERIMENTAL
Intervention: Pharmacist-directed medication reconciliation
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (no pharmacist-directed medication reconciliation)
Number of subjects: 123
Study: 34874631

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery and platinum-based chemotherapy
Number of subjects: 407

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (complete resection)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Quality of life measures
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Perioperative mortality
Number of subjects: 407
Study: 34387227

Group type: EXPERIMENTAL
Intervention: Artificial Intelligence (AI) convolutional neural networks (CNN)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group assessment
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Expert radiologist aided by AI
Number of subjects: 143
Study: 34883480

Group type: EXPERIMENTAL
Intervention: Standardised multidisciplinary education programme
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 142
Study: 34277507

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined training (CT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34298113

Group type: EXPERIMENTAL
Intervention: 3D-printed oblong tablets
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3D-printed round tablets
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3D-printed football
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3D-printed sphere
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3D-printed pyramid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3D-printed cuboctahedron
Number of subjects: 12

Group type: COMPARATOR
Intervention: Compressed placebo reference objects
Number of subjects: 12
Study: 32444968

Group type: EXPERIMENTAL
Intervention: Low-pass-filtered sentence intonation (SI-LPF) test
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sentence test with adaptive randomized roving level (STARR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sentence recognition tests presented in quiet (SRQ)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Fixed signal-to-noise ratios (SNRs at +10 dB)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Fixed signal-to-noise ratios (SNRs at +5 dB)
Number of subjects: 17
Study: 33279463

Group type: EXPERIMENTAL
Intervention: High-Fat, High-Protein Meat (HFPM) diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate Vegan (HCV) diet
Number of subjects: 8
Study: 33074848

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NIPPV)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham ventilation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 19
Study: 34746997

Group type: EXPERIMENTAL
Intervention: Melatonin (3mg) plus Tamsulosin (0.4mg)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo plus Tamsulosin (0.4mg)
Number of subjects: 108
Study: 33793743

Group type: EXPERIMENTAL
Intervention: OABP+ (Oral Antibiotic Prophylaxis with Mechanical Bowel Preparation)
Number of subjects: 600

Group type: COMPARATOR
Intervention: OABP- (No Oral Antibiotic Prophylaxis with Mechanical Bowel Preparation)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: OABP+
Number of subjects: 600

Group type: COMPARATOR
Intervention: OABP-
Number of subjects: 600
Study: 32694544

Group type: COMPARATOR
Intervention: FSBM0 (27% SBM + 0% FSBM)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: FSBM9 (18% SBM + 9% FSBM)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: FSBM13 (13.5% SBM + 13.5% FSBM)
Number of subjects: 39
Study: 33242717

Group type: EXPERIMENTAL
Intervention: Bikram yoga
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 53

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 53
Study: 32338532

Group type: EXPERIMENTAL
Intervention: Ischaemic compression (IC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 32437711

Group type: EXPERIMENTAL
Intervention: RFA + S-1
Number of subjects: 75

Group type: COMPARATOR
Intervention: RFA
Number of subjects: 75
Study: 36416000

Group type: EXPERIMENTAL
Intervention: IWL (internet weight-loss intervention only)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: IWL + PCP (internet weight-loss intervention plus semiautomated feedback from the provider)
Number of subjects: 550

Group type: COMPARATOR
Intervention: EUC (usual care)
Number of subjects: 550
Study: 33218552

Group type: EXPERIMENTAL
Intervention: Squats performed with 60% of 1-RM
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Functional exercises (sit-to-stand, lunges, and step-ups)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cycling and running
Number of subjects: 14
Study: 34949502

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TA) drops
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral prednisolone (OP)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 32037862

Group type: EXPERIMENTAL
Intervention: Pressure garment application (long glove) for 6 hours/day in addition to 2 hours/week conventional occupational therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional occupational therapy for 2 hours/week
Number of subjects: 46
Study: 36194950

Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2, 6 cycles, three-weekly)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Paclitaxel (80 mg/m2, weekly)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 158

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 158
Study: 35551978

Group type: EXPERIMENTAL
Intervention: Qirui Weishu capsule
Number of subjects: 477

Group type: COMPARATOR
Intervention: Sanjiu Weitai capsule
Number of subjects: 477
Study: 34380364

Group type: EXPERIMENTAL
Intervention: Titrated CCRT
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Non-titrated CCRT
Number of subjects: 201
Study: 34380299

Group type: EXPERIMENTAL
Intervention: Local magneto-therapy
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: General magneto-therapy
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (therapeutic exercises only)
Number of subjects: 114
Study: 32160755

Group type: EXPERIMENTAL
Intervention: ACTG 5366 trial participation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Reimbursements to defray costs of study participation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Understanding of risks and benefits
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Stigma as a motivator
Number of subjects: 31
Study: 34480330

Group type: EXPERIMENTAL
Intervention: Active deep brain stimulation (DN DBS)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 5
Study: 33320296

Group type: EXPERIMENTAL
Intervention: Condition 1: Walking without any irritation
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Condition 2: Imitated sacculus irritation using a standardized cVEMP signal
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Condition 3: Electric neck muscle-irritation (TENS)
Number of subjects: 7
Study: 33393688

Group type: EXPERIMENTAL
Intervention: Prompt Mental Health Care (PMHC)
Number of subjects: 839

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 839
Study: 32102662

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich diet (PR-diet)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control diet (C-diet)
Number of subjects: 50
Study: 35652491

Group type: EXPERIMENTAL
Intervention: Restrictive IV fluid administration (24 hours)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard care (at the discretion of the treating team)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Restrictive IV fluid administration
Number of subjects: 123

Group type: COMPARATOR
Intervention: Restrictive IV fluid administration and Standard care
Number of subjects: 123
Study: 34411264

Group type: EXPERIMENTAL
Intervention: Cefdinir (or trimethoprim‐sulfamethoxazole for intolerant patients) for 7 days after surgery
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo for 7 days after surgery
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Cefdinir (or trimethoprim‐sulfamethoxazole for intolerant patients)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 32593627

Group type: EXPERIMENTAL
Intervention: Disposable circumcision suture device
Number of subjects: 284

Group type: COMPARATOR
Intervention: Conventional dorsal slit circumcision
Number of subjects: 284
Study: 36066862

Group type: COMPARATOR
Intervention: Medication management (MM)
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Medication management plus combined behavioral intervention (MMCBI)
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 947
Study: 34086781

Group type: EXPERIMENTAL
Intervention: Out-of-pocket (OOP) payments for healthcare in HDP areas
Number of subjects: 3791

Group type: COMPARATOR
Intervention: Out-of-pocket (OOP) payments for healthcare in LDP areas
Number of subjects: 3791

Group type: EXPERIMENTAL
Intervention: Catastrophic healthcare expenditure
Number of subjects: 3791

Group type: EXPERIMENTAL
Intervention: Non-communicable diseases (NCDs)
Number of subjects: 3791

Group type: EXPERIMENTAL
Intervention: Overall impoverishment due to OOP payments
Number of subjects: 3791
Study: 35494290

Group type: EXPERIMENTAL
Intervention: Theracurmin at 180 mg per day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32936242

Group type: EXPERIMENTAL
Intervention: Prophylactic SAE (pSAE)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Surveillance (SURV)
Number of subjects: 133
Study: 35123930

Group type: EXPERIMENTAL
Intervention: Arabin pessary
Number of subjects: 315

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 315
Study: 33433317

Group type: EXPERIMENTAL
Intervention: tofacitinib citrate test formulation (T)
Number of subjects: 72

Group type: COMPARATOR
Intervention: tofacitinib citrate reference formulation (R)
Number of subjects: 72
Study: 35986905

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention for less chronic heart failure (NIL-CHF)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Normal echocardiogram
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Left ventricular diastolic dysfunction/left ventricular systolic dysfunction (LVDD/LVSD)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Structural heart disease
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Mortality
Number of subjects: 454
Study: 34465695

Group type: EXPERIMENTAL
Intervention: Linaclotide 290 μg daily for 12 weeks
Number of subjects: 614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study: 32886256

Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 100

Group type: COMPARATOR
Intervention: TAPP
Number of subjects: 100
Study: 32911214

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (laboratory tests and free ART medication)
Number of subjects: 20
Study: 36120840

Group type: EXPERIMENTAL
Intervention: Ultrahigh-translucent monolithic zirconia (group Z)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resin-matrix ceramic (group C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Polyetherketoneketone veneered with light-cured composite resin (group P)
Number of subjects: 30
Study: 33089368

Group type: COMPARATOR
Intervention: Physical therapy (transcutaneous electrical nerve stimulation, hot pack, ultrasound treatments, Codman's and range of motion exercises)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Balneotherapy added to physical therapy
Number of subjects: 90
Study: 35551237

Group type: EXPERIMENTAL
Intervention: Decompression and drainage seton (DADS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cutting seton (CS)
Number of subjects: 120
Study: 32484432

Group type: EXPERIMENTAL
Intervention: Carer administration of as-needed subcutaneous medication (intervention group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall recruitment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall retention
Number of subjects: 40
Study: 36175107

Group type: EXPERIMENTAL
Intervention: Deliberate practice training using role-play and Skillsetter, an online skill-building system with therapy videos, for 15 hours of classroom participation and homework.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Theoretical teaching for 15 hours of classroom participation and homework.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Deliberate practice training
Number of subjects: 200
Study: 33462097

Group type: EXPERIMENTAL
Intervention: DAFNEplus intervention
Number of subjects: 662

Group type: COMPARATOR
Intervention: Standard DAFNE
Number of subjects: 662
Study: 32409561

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus standard of care
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine recipients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Hydroxychloroquine non-recipients
Number of subjects: 150
Study: 35034532

Group type: EXPERIMENTAL
Intervention: Optimised regimen (7 × 2 L 2.27% glucose + 5 × 2 L 0.1% glucose over 8 h)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard regimen (6 × 2 L 1.36% glucose over 9 h)
Number of subjects: 21
Study: 33354953

Group type: EXPERIMENTAL
Intervention: Psychological nursing
Number of subjects: 160
Study: 34511283

Group type: EXPERIMENTAL
Intervention: CHOICES Decision Aid (DA)
Number of subjects: 101

Group type: COMPARATOR
Intervention: National Cancer Institute (NCI) Cancer Clinical Trials (CCT) website
Number of subjects: 101
Study: 32542644

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV-vaccine
Number of subjects: 6203

Group type: COMPARATOR
Intervention: Prevaccination data
Number of subjects: 6203
Study: 36104302

Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg as an intact tablet
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg crushed and mixed with applesauce
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg (both intact and crushed)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vibegron and applesauce mixture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vibegron crushed and mixed with applesauce
Number of subjects: 30
Study: 33963943

Group type: EXPERIMENTAL
Intervention: 0.05% EGCG solution + RelyX U200
Number of subjects: 144

Group type: COMPARATOR
Intervention: 2% chlorhexidine (CHX) solution
Number of subjects: 144

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Conventional resin cement
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Thermal cycling (5 °C/55 °C, 12,000 cycles)
Number of subjects: 144
Study: 33327746

Group type: EXPERIMENTAL
Intervention: Lower HDL cholesterol (1 mmol/L or 39 mg/dL)
Number of subjects: 107952

Group type: EXPERIMENTAL
Intervention: Genetically determined lower HDL cholesterol (1 mmol/L or 39 mg/dL)
Number of subjects: 107952
Study: 33851547

Group type: EXPERIMENTAL
Intervention: Green Dot (GD) training after high school
Number of subjects: 1831

Group type: COMPARATOR
Intervention: Control condition (no additional GD training)
Number of subjects: 1831

Group type: EXPERIMENTAL
Intervention: Additional GD training after RCT
Number of subjects: 1831
Study: 32308115

Group type: EXPERIMENTAL
Intervention: Uterine volume measurement
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Right ovarian volume measurement
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Left ovarian volume measurement
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Endometrial thickness measurement
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Prevalence of ultrasound-detected gynecological pathology
Number of subjects: 815
Study: 33155565

Group type: EXPERIMENTAL
Intervention: Hip arthrography
Number of subjects: 47
Study: 34791007

Group type: EXPERIMENTAL
Intervention: Camelina oil (1.5 g ALA/d)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 33706617

Group type: EXPERIMENTAL
Intervention: BladderScan feedback method
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 11